Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 328

    1.

    Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

    Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA.

    Ann Intern Med. 2007 Aug 21;147(4):251-62. Review.PMID: 17709759 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.

    McAlister FA, Ezekowitz J, Dryden DM, Hooton N, Vandermeer B, Friesen C, Spooner C, Rowe BH.

    Evid Rep Technol Assess (Full Rep). 2007 Jun;(152):1-199. Review.PMID: 17764218 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.

    McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH.

    JAMA. 2007 Jun 13;297(22):2502-14. Review.PMID: 17565085 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

    Ezekowitz JA, Armstrong PW, McAlister FA.

    Ann Intern Med. 2003 Mar 18;138(6):445-52. Review.PMID: 12639076 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

    Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review.

    Bryant J, Brodin H, Loveman E, Payne E, Clegg A.

    Health Technol Assess. 2005 Sep;9(36):1-150, iii. Review.PMID: 16153353 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Systematic review: cardiac resynchronization in patients with symptomatic heart failure.

    McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, Klassen T, Abraham W.

    Ann Intern Med. 2004 Sep 7;141(5):381-90. Epub 2004 Aug 16. Review. Erratum in: Ann Intern Med. 2005 Feb 15;142(4):311. PMID: 15353430 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials.

    Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR.

    JAMA. 2003 Feb 12;289(6):730-40.PMID: 12585952 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

    Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

    Arch Intern Med. 2009 Sep 14;169(16):1500-6.PMID: 19752408 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.

    Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS.

    J Am Coll Cardiol. 2004 Dec 7;44(11):2166-72.PMID: 15582314 [PubMed - indexed for MEDLINE]Related articles

    11.

    Implantable cardioverter-defibrillators: expanding indications and technologies.

    Goldberger Z, Lampert R.

    JAMA. 2006 Feb 15;295(7):809-18. Review.PMID: 16478904 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.

    Toma M, McAlister FA, Ezekowitz J, Kimber S, Gulamhusein S, Pantano A, Sivakumaran S, Cujec B, Paterson I, Armstrong PW.

    Am J Cardiol. 2006 Mar 15;97(6):882-5. Epub 2006 Jan 30.PMID: 16516594 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.

    Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S.

    Arch Intern Med. 2006 Nov 13;166(20):2228-33.PMID: 17101941 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.

    Desai AS, Fang JC, Maisel WH, Baughman KL.

    JAMA. 2004 Dec 15;292(23):2874-9. Review.PMID: 15598919 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effectiveness and safety of vitamin D in relation to bone health.

    Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

    Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.

    J Am Coll Cardiol. 2006 Jul 4;48(1):112-21. Epub 2006 Jun 9.PMID: 16814657 [PubMed - indexed for MEDLINE]Related articles

    17.

    The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits.

    Jolly S, Dorian P, Alter DA.

    J Eval Clin Pract. 2006 Apr;12(2):190-5.PMID: 16579828 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation.

    Bryant J, Brodin H, Loveman E, Clegg A.

    Int J Technol Assess Health Care. 2007 Winter;23(1):63-70. Review.PMID: 17234018 [PubMed - indexed for MEDLINE]Related articles

    19.

    Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices.

    Naccarelli GV.

    Clin Cardiol. 2005 Nov;28(11 Suppl 1):I51-7. Review.PMID: 16450813 [PubMed - indexed for MEDLINE]Related articles

    20.

    Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness.

    Parkes J, Bryant J, Milne R.

    Heart. 2002 May;87(5):438-42. Review.PMID: 11997415 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data